resistance/intolerance to second generation tkis in cml: what to do next?
Published 5 years ago • 56 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
3:20
the current standard of care in cml and insights into the use of first- and second-generation tkis
-
2:11
addressing the issue of resistance to tkis in cml
-
2:45
understanding the cause of tki resistance to improve management strategies in cml
-
1:46
benefits of second generation tkis for cml in the frontline
-
6:22
efficacy & tolerability of available tki therapies in cml & managing tki resistance
-
1:04
combining autophagy inhibitors with tkis in cml
-
1:22
unmet needs in cml: increasing treatment-free remission & accessibility to tkis
-
1:12
the role of cml stem cells in relapse after tki discontinuation & resistance to treatment
-
1:39
emerging therapeutic approaches for tki-resistant cml
-
3:12
second-generation tyrosine kinase inhibitors for chronic myeloid leukemia
-
8:19
cml: considering second-generation tkis
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
2:17
current cml treatments: which tki to choose?
-
3:37
clonal evolution and resistance mechanisms to bcl-2 receptor inhibition
-
4:02
testing for bcr::abl kinase mutations in cml and how they impact tki resistance
-
2:35
resistance to immunotherapy in multiple myeloma: mechanisms & monitoring
-
3:18
predictors for tfr in cml: response duration, secondary treatment & frontline tki choice
-
1:24
considerations for tki choice in frontline and r/r cml
-
2:37
resistance to acalabrutinib in cll is mediated by btk mutations